In this regard, scoparone was reported to inhibit Ang II-induced cardiac hypertrophy in vitro via the elimination of overexpression of RAC1 and by inhibiting RAC1-mediated oxidative stress [170,171]. The gene discussed is RAC1; the disease is cardiac hypertrophy.